Literature DB >> 25801602

Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia.

Cédric Aumont1, Françoise Driss2, Thierry Lazure3, Véronique Picard1, Rita Creidy1, Stéphane De Botton4,5, Véronique Saada6, Olivier Lambotte2,5, Chrystèle Bilhou-Nabera1, Gérard Tertian1,5, Jean-Marie Michot2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25801602     DOI： 10.1002/ajh.24010

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation.

Authors:  Jack Y Ghannam; Xin Xu; Irina Maric; Laura Dillon; Yuesheng Li; Matthew M Hsieh; Christopher S Hourigan; Courtney D Fitzhugh
Journal:  Blood       Date:  2020-04-02       Impact factor: 22.113

2.  Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.

Authors:  Matthew M Hsieh; Melissa Bonner; Francis John Pierciey; Naoya Uchida; James Rottman; Laura Demopoulos; Manfred Schmidt; Julie Kanter; Mark C Walters; Alexis A Thompson; Mohammed Asmal; John F Tisdale
Journal:  Blood Adv       Date:  2020-05-12

3.  Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.

Authors:  Javier Bolaños-Meade; Kenneth R Cooke; Christopher J Gamper; Syed Abbas Ali; Richard F Ambinder; Ivan M Borrello; Ephraim J Fuchs; Douglas E Gladstone; Christian B Gocke; Carol Ann Huff; Leo Luznik; Lode J Swinnen; Heather J Symons; Stephanie A Terezakis; Nina Wagner-Johnston; Richard J Jones; Robert A Brodsky
Journal:  Lancet Haematol       Date:  2019-03-14       Impact factor: 18.959

Review 4.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Angela E Rankine-Mullings; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

Review 5.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Sarah J Nevitt; Ashley P Jones; Jo Howard
Journal:  Cochrane Database Syst Rev       Date:  2017-04-20

6.  Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea.

Authors:  Dhiraj Kumar Yadav; Thushara Paul; Mohamed Alhamar; Kedar Inamdar; Yue Guo
Journal:  Case Rep Oncol       Date:  2020-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.